<DOC>
	<DOCNO>NCT00612157</DOCNO>
	<brief_summary>The purpose study assess efficacy Eszopiclone improve short intermediate-term compliance continuous positive airway pressure ( CPAP ) patient newly diagnose obstructive sleep apnea ( OSA ) .</brief_summary>
	<brief_title>Continuous Positive Airway Pressure ( CPAP ) Promotion And Prognosis - Army Sleep Apnea Program ( ASAP )</brief_title>
	<detailed_description>CPAP treatment choice patient OSA . However , patient frequently intolerant therapy initially . After continue use , tolerance achieve . However , initial discomfort intolerance frequently lead patient-initiated discontinuation therapy . It show CPAP use 1 month predicts use 6 month 1 year . Patients initially struggle intolerant CPAP frequently abandon therapy unlikely use long term . To prevent , sleep physician often prescribe short course sedatives help improve initial tolerance promote well compliance therapy . However , effectiveness practice validate clinical trial . Compliance , reference study willingness patient follow prescribed course treatment .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<criteria>Adult patient Newly diagnose OSA prescribe CPAP therapy Patients &lt; 18 year old Patients 65 year Pregnant woman Patients chronic liver disease Patients abuse alcohol Patients take narcotic use sedativehypnotic agent Ambien , Klonopin Benadryl</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>Continuous Positive Airway Pressure</keyword>
	<keyword>CPAP Compliance</keyword>
	<keyword>Non-benzodiazepine hypnotic</keyword>
</DOC>